Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
31 |
1929 |
3.37e-16 |
1.568e-12 |
2 |
POSITIVE REGULATION OF CELL COMMUNICATION |
27 |
1532 |
7.367e-15 |
1.714e-11 |
3 |
REGULATION OF CELL DEATH |
26 |
1472 |
2.741e-14 |
4.251e-11 |
4 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
25 |
1656 |
3.517e-12 |
4.091e-09 |
5 |
NEGATIVE REGULATION OF CELL DEATH |
18 |
872 |
6.093e-11 |
5.091e-08 |
6 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
18 |
876 |
6.565e-11 |
5.091e-08 |
7 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
19 |
1087 |
2.678e-10 |
1.558e-07 |
8 |
REGULATION OF PROTEOLYSIS |
16 |
711 |
2.512e-10 |
1.558e-07 |
9 |
NEUROGENESIS |
21 |
1402 |
3.996e-10 |
2.066e-07 |
10 |
CELL DEVELOPMENT |
21 |
1426 |
5.449e-10 |
2.536e-07 |
11 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
18 |
1036 |
9.841e-10 |
3.522e-07 |
12 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
23 |
1791 |
9.055e-10 |
3.522e-07 |
13 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
18 |
1036 |
9.841e-10 |
3.522e-07 |
14 |
IMMUNE SYSTEM PROCESS |
24 |
1984 |
1.122e-09 |
3.73e-07 |
15 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
22 |
1672 |
1.542e-09 |
4.784e-07 |
16 |
NOTCH SIGNALING PATHWAY |
8 |
114 |
1.99e-09 |
5.788e-07 |
17 |
POSITIVE REGULATION OF CELL DEATH |
14 |
605 |
2.809e-09 |
7.69e-07 |
18 |
LOCOMOTION |
18 |
1114 |
3.11e-09 |
8.04e-07 |
19 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
17 |
983 |
3.447e-09 |
8.442e-07 |
20 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
13 |
513 |
3.816e-09 |
8.877e-07 |
21 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
18 |
1152 |
5.268e-09 |
1.167e-06 |
22 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
17 |
1021 |
6.081e-09 |
1.286e-06 |
23 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
15 |
771 |
7.277e-09 |
1.472e-06 |
24 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
17 |
1079 |
1.382e-08 |
2.679e-06 |
25 |
DEFENSE RESPONSE |
18 |
1231 |
1.48e-08 |
2.755e-06 |
26 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
19 |
1395 |
1.659e-08 |
2.97e-06 |
27 |
IMMUNE RESPONSE |
17 |
1100 |
1.836e-08 |
3.164e-06 |
28 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
20 |
1618 |
3.168e-08 |
5.264e-06 |
29 |
LEUKOCYTE ACTIVATION |
11 |
414 |
4.323e-08 |
6.936e-06 |
30 |
POSITIVE REGULATION OF LOCOMOTION |
11 |
420 |
5.004e-08 |
7.167e-06 |
31 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
19 |
1492 |
4.882e-08 |
7.167e-06 |
32 |
NEGATIVE REGULATION OF NEURON DEATH |
8 |
171 |
4.853e-08 |
7.167e-06 |
33 |
BIOLOGICAL ADHESION |
16 |
1032 |
5.083e-08 |
7.167e-06 |
34 |
CELLULAR COMPONENT MORPHOGENESIS |
15 |
900 |
5.669e-08 |
7.758e-06 |
35 |
NEURON PROJECTION DEVELOPMENT |
12 |
545 |
7.674e-08 |
9.986e-06 |
36 |
LYMPHOCYTE ACTIVATION |
10 |
342 |
7.801e-08 |
9.986e-06 |
37 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
20 |
1710 |
7.941e-08 |
9.986e-06 |
38 |
REGULATION OF CELL MORPHOGENESIS |
12 |
552 |
8.814e-08 |
1.079e-05 |
39 |
CELL ACTIVATION |
12 |
568 |
1.201e-07 |
1.397e-05 |
40 |
REGULATION OF NEURON APOPTOTIC PROCESS |
8 |
192 |
1.188e-07 |
1.397e-05 |
41 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
14 |
829 |
1.454e-07 |
1.65e-05 |
42 |
CELL MOTILITY |
14 |
835 |
1.588e-07 |
1.666e-05 |
43 |
LOCALIZATION OF CELL |
14 |
835 |
1.588e-07 |
1.666e-05 |
44 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
17 |
1275 |
1.568e-07 |
1.666e-05 |
45 |
REGULATION OF CELL DEVELOPMENT |
14 |
836 |
1.611e-07 |
1.666e-05 |
46 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
7 |
135 |
1.758e-07 |
1.779e-05 |
47 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
16 |
1135 |
1.874e-07 |
1.856e-05 |
48 |
CELL DEATH |
15 |
1001 |
2.256e-07 |
2.163e-05 |
49 |
LYMPHOCYTE DIFFERENTIATION |
8 |
209 |
2.278e-07 |
2.163e-05 |
50 |
LEUKOCYTE DIFFERENTIATION |
9 |
292 |
2.377e-07 |
2.212e-05 |
51 |
REGULATION OF CATABOLIC PROCESS |
13 |
731 |
2.427e-07 |
2.214e-05 |
52 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
10 |
393 |
2.828e-07 |
2.437e-05 |
53 |
NEURON DIFFERENTIATION |
14 |
874 |
2.767e-07 |
2.437e-05 |
54 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
11 |
498 |
2.776e-07 |
2.437e-05 |
55 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
9 |
304 |
3.337e-07 |
2.823e-05 |
56 |
NEURON PROJECTION MORPHOGENESIS |
10 |
402 |
3.481e-07 |
2.893e-05 |
57 |
PROTEOLYSIS |
16 |
1208 |
4.349e-07 |
3.55e-05 |
58 |
NEGATIVE REGULATION OF PROTEOLYSIS |
9 |
329 |
6.466e-07 |
5.187e-05 |
59 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
13 |
801 |
6.853e-07 |
5.405e-05 |
60 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
337 |
7.897e-07 |
6.125e-05 |
61 |
REGULATION OF CELL PROJECTION ORGANIZATION |
11 |
558 |
8.538e-07 |
6.513e-05 |
62 |
NEURON DEVELOPMENT |
12 |
687 |
9.127e-07 |
6.842e-05 |
63 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
12 |
689 |
9.41e-07 |
6.842e-05 |
64 |
REGULATION OF NEURON DEATH |
8 |
252 |
9.407e-07 |
6.842e-05 |
65 |
NEURON MIGRATION |
6 |
110 |
1.048e-06 |
7.499e-05 |
66 |
RESPONSE TO CYTOKINE |
12 |
714 |
1.367e-06 |
9.636e-05 |
67 |
REGULATION OF CELL DIFFERENTIATION |
17 |
1492 |
1.43e-06 |
9.93e-05 |
68 |
POSITIVE REGULATION OF PROTEOLYSIS |
9 |
363 |
1.461e-06 |
9.999e-05 |
69 |
REGULATION OF CELL PROLIFERATION |
17 |
1496 |
1.484e-06 |
1e-04 |
70 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
9 |
368 |
1.636e-06 |
0.0001087 |
71 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
17 |
1518 |
1.814e-06 |
0.0001189 |
72 |
CELL CYCLE CHECKPOINT |
7 |
194 |
2.031e-06 |
0.0001313 |
73 |
REGULATION OF BINDING |
8 |
283 |
2.239e-06 |
0.0001427 |
74 |
POSITIVE REGULATION OF BINDING |
6 |
127 |
2.429e-06 |
0.0001527 |
75 |
REGULATION OF PEPTIDASE ACTIVITY |
9 |
392 |
2.746e-06 |
0.0001703 |
76 |
POSITIVE REGULATION OF PROTEIN BINDING |
5 |
73 |
2.86e-06 |
0.0001747 |
77 |
CELL PART MORPHOGENESIS |
11 |
633 |
2.904e-06 |
0.0001747 |
78 |
NEURON PROJECTION GUIDANCE |
7 |
205 |
2.929e-06 |
0.0001747 |
79 |
REGULATION OF IMMUNE SYSTEM PROCESS |
16 |
1403 |
3.128e-06 |
0.0001843 |
80 |
EXTRACELLULAR MATRIX DISASSEMBLY |
5 |
76 |
3.494e-06 |
0.0002032 |
81 |
GLIAL CELL DIFFERENTIATION |
6 |
136 |
3.615e-06 |
0.0002077 |
82 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
9 |
408 |
3.803e-06 |
0.0002158 |
83 |
REGULATION OF MAPK CASCADE |
11 |
660 |
4.332e-06 |
0.0002344 |
84 |
REGULATION OF SYNAPTIC PLASTICITY |
6 |
140 |
4.275e-06 |
0.0002344 |
85 |
PROTEIN PHOSPHORYLATION |
13 |
944 |
4.237e-06 |
0.0002344 |
86 |
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY |
4 |
36 |
4.288e-06 |
0.0002344 |
87 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
11 |
662 |
4.458e-06 |
0.0002357 |
88 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
11 |
662 |
4.458e-06 |
0.0002357 |
89 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
6 |
143 |
4.832e-06 |
0.0002526 |
90 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
12 |
823 |
5.911e-06 |
0.0003056 |
91 |
REGULATION OF NEURON DIFFERENTIATION |
10 |
554 |
6.21e-06 |
0.0003175 |
92 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
14 |
1142 |
6.515e-06 |
0.0003295 |
93 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
7 |
232 |
6.613e-06 |
0.0003309 |
94 |
RESPONSE TO WOUNDING |
10 |
563 |
7.152e-06 |
0.000354 |
95 |
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY |
7 |
245 |
9.438e-06 |
0.0004623 |
96 |
SINGLE ORGANISM CELL ADHESION |
9 |
459 |
9.829e-06 |
0.0004764 |
97 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
12 |
867 |
1.001e-05 |
0.0004802 |
98 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
15 |
1360 |
1.024e-05 |
0.0004861 |
99 |
REGULATION OF PROTEIN BINDING |
6 |
168 |
1.217e-05 |
0.0005668 |
100 |
FOREBRAIN DEVELOPMENT |
8 |
357 |
1.23e-05 |
0.0005668 |
101 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
9 |
472 |
1.228e-05 |
0.0005668 |
102 |
INTRACELLULAR SIGNAL TRANSDUCTION |
16 |
1572 |
1.333e-05 |
0.000608 |
103 |
LEUKOCYTE MIGRATION |
7 |
259 |
1.354e-05 |
0.0006115 |
104 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
8 |
363 |
1.388e-05 |
0.0006209 |
105 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
10 |
609 |
1.416e-05 |
0.0006276 |
106 |
CELL PROJECTION ORGANIZATION |
12 |
902 |
1.488e-05 |
0.0006532 |
107 |
GLIOGENESIS |
6 |
175 |
1.535e-05 |
0.0006675 |
108 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
10 |
616 |
1.563e-05 |
0.0006734 |
109 |
RESPONSE TO EXTERNAL STIMULUS |
17 |
1821 |
2.07e-05 |
0.0008835 |
110 |
POSITIVE REGULATION OF TRANSPORT |
12 |
936 |
2.149e-05 |
0.0009091 |
111 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
8 |
395 |
2.545e-05 |
0.001048 |
112 |
REGULATION OF RESPONSE TO STRESS |
15 |
1468 |
2.534e-05 |
0.001048 |
113 |
ERROR PRONE TRANSLESION SYNTHESIS |
3 |
19 |
2.526e-05 |
0.001048 |
114 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
8 |
397 |
2.638e-05 |
0.001077 |
115 |
VIRAL LIFE CYCLE |
7 |
290 |
2.8e-05 |
0.001133 |
116 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
6 |
195 |
2.828e-05 |
0.001134 |
117 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
6 |
200 |
3.26e-05 |
0.001296 |
118 |
RHYTHMIC PROCESS |
7 |
298 |
3.33e-05 |
0.001313 |
119 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
3 |
21 |
3.453e-05 |
0.00135 |
120 |
REGULATION OF HYDROLASE ACTIVITY |
14 |
1327 |
3.526e-05 |
0.001365 |
121 |
MODULATION OF SYNAPTIC TRANSMISSION |
7 |
301 |
3.549e-05 |
0.001365 |
122 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
7 |
303 |
3.702e-05 |
0.001412 |
123 |
FOREBRAIN CELL MIGRATION |
4 |
62 |
3.827e-05 |
0.001448 |
124 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
3 |
22 |
3.989e-05 |
0.001497 |
125 |
ORGAN MORPHOGENESIS |
11 |
841 |
4.151e-05 |
0.001545 |
126 |
NEGATIVE REGULATION OF ION TRANSPORT |
5 |
127 |
4.269e-05 |
0.001576 |
127 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
6 |
213 |
4.635e-05 |
0.001698 |
128 |
REGULATION OF IMMUNE RESPONSE |
11 |
858 |
4.977e-05 |
0.001809 |
129 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
13 |
1192 |
5.041e-05 |
0.001818 |
130 |
POSITIVE REGULATION OF NEURON DEATH |
4 |
67 |
5.199e-05 |
0.001819 |
131 |
REGULATION OF NOTCH SIGNALING PATHWAY |
4 |
67 |
5.199e-05 |
0.001819 |
132 |
RESPONSE TO ABIOTIC STIMULUS |
12 |
1024 |
5.176e-05 |
0.001819 |
133 |
REGULATION OF MAP KINASE ACTIVITY |
7 |
319 |
5.128e-05 |
0.001819 |
134 |
CELLULAR RESPONSE TO STRESS |
15 |
1565 |
5.325e-05 |
0.001849 |
135 |
IMMUNE SYSTEM DEVELOPMENT |
9 |
582 |
6.33e-05 |
0.002182 |
136 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
5 |
139 |
6.565e-05 |
0.00223 |
137 |
MITOTIC CELL CYCLE CHECKPOINT |
5 |
139 |
6.565e-05 |
0.00223 |
138 |
INFLAMMATORY RESPONSE |
8 |
454 |
6.802e-05 |
0.002289 |
139 |
PHOSPHORYLATION |
13 |
1228 |
6.839e-05 |
0.002289 |
140 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
16 |
1805 |
7.251e-05 |
0.00241 |
141 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
6 |
232 |
7.443e-05 |
0.002456 |
142 |
RESPONSE TO TUMOR NECROSIS FACTOR |
6 |
233 |
7.622e-05 |
0.002498 |
143 |
TAXIS |
8 |
464 |
7.918e-05 |
0.002576 |
144 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
145 |
8.022e-05 |
0.002592 |
145 |
SENSORY PERCEPTION OF PAIN |
4 |
75 |
8.096e-05 |
0.002598 |
146 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
10 |
750 |
8.264e-05 |
0.002623 |
147 |
T CELL RECEPTOR SIGNALING PATHWAY |
5 |
146 |
8.287e-05 |
0.002623 |
148 |
RESPONSE TO COPPER ION |
3 |
28 |
8.376e-05 |
0.002633 |
149 |
POSITIVE REGULATION OF MAPK CASCADE |
8 |
470 |
8.658e-05 |
0.002686 |
150 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
9 |
606 |
8.624e-05 |
0.002686 |
151 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
5 |
148 |
8.838e-05 |
0.002723 |
152 |
RESPONSE TO GROWTH FACTOR |
8 |
475 |
9.317e-05 |
0.002852 |
153 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
16 |
1848 |
9.599e-05 |
0.002919 |
154 |
INNATE IMMUNE RESPONSE |
9 |
619 |
0.0001014 |
0.003062 |
155 |
POSITIVE REGULATION OF KINASE ACTIVITY |
8 |
482 |
0.0001031 |
0.003095 |
156 |
REGULATION OF KINASE ACTIVITY |
10 |
776 |
0.0001095 |
0.003266 |
157 |
REGULATION OF CELL ADHESION |
9 |
629 |
0.0001144 |
0.003392 |
158 |
REGULATION OF TRANSFERASE ACTIVITY |
11 |
946 |
0.0001192 |
0.003509 |
159 |
REGULATION OF ERBB SIGNALING PATHWAY |
4 |
83 |
0.0001202 |
0.003517 |
160 |
ENDOCARDIAL CUSHION DEVELOPMENT |
3 |
32 |
0.0001257 |
0.003589 |
161 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
3 |
32 |
0.0001257 |
0.003589 |
162 |
BLOOD VESSEL REMODELING |
3 |
32 |
0.0001257 |
0.003589 |
163 |
LEUKOCYTE CELL CELL ADHESION |
6 |
255 |
0.0001251 |
0.003589 |
164 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
11 |
957 |
0.0001319 |
0.003698 |
165 |
PALATE DEVELOPMENT |
4 |
85 |
0.0001318 |
0.003698 |
166 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
4 |
85 |
0.0001318 |
0.003698 |
167 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
5 |
162 |
0.0001352 |
0.003723 |
168 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
162 |
0.0001352 |
0.003723 |
169 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
5 |
162 |
0.0001352 |
0.003723 |
170 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
4 |
87 |
0.0001443 |
0.003789 |
171 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
4 |
87 |
0.0001443 |
0.003789 |
172 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
6 |
262 |
0.000145 |
0.003789 |
173 |
PROTEIN LOCALIZATION TO MEMBRANE |
7 |
376 |
0.000143 |
0.003789 |
174 |
VIRAL ENTRY INTO HOST CELL |
4 |
87 |
0.0001443 |
0.003789 |
175 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
4 |
87 |
0.0001443 |
0.003789 |
176 |
MOVEMENT IN HOST ENVIRONMENT |
4 |
87 |
0.0001443 |
0.003789 |
177 |
ENTRY INTO HOST |
4 |
87 |
0.0001443 |
0.003789 |
178 |
ENTRY INTO HOST CELL |
4 |
87 |
0.0001443 |
0.003789 |
179 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
6 |
263 |
0.000148 |
0.003847 |
180 |
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY |
3 |
34 |
0.000151 |
0.003862 |
181 |
AGING |
6 |
264 |
0.0001511 |
0.003862 |
182 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
4 |
88 |
0.0001508 |
0.003862 |
183 |
PROTEIN MATURATION |
6 |
265 |
0.0001542 |
0.003921 |
184 |
B CELL DIFFERENTIATION |
4 |
89 |
0.0001575 |
0.003984 |
185 |
REGULATION OF AXONOGENESIS |
5 |
168 |
0.0001603 |
0.004032 |
186 |
POSITIVE REGULATION OF CELL PROLIFERATION |
10 |
814 |
0.0001619 |
0.00405 |
187 |
POSITIVE REGULATION OF GENE EXPRESSION |
15 |
1733 |
0.0001683 |
0.004187 |
188 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
6 |
274 |
0.0001848 |
0.004574 |
189 |
VIRION ASSEMBLY |
3 |
37 |
0.0001948 |
0.004796 |
190 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
4 |
95 |
0.0002026 |
0.004962 |
191 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
4 |
96 |
0.0002109 |
0.005115 |
192 |
MESENCHYME MORPHOGENESIS |
3 |
38 |
0.0002111 |
0.005115 |
193 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
5 |
179 |
0.0002154 |
0.005192 |
194 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
7 |
404 |
0.0002222 |
0.005329 |
195 |
ERBB2 SIGNALING PATHWAY |
3 |
39 |
0.0002282 |
0.005389 |
196 |
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
3 |
39 |
0.0002282 |
0.005389 |
197 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
3 |
39 |
0.0002282 |
0.005389 |
198 |
REGULATION OF TRANSPORT |
15 |
1804 |
0.0002616 |
0.006148 |
199 |
TRANSLESION SYNTHESIS |
3 |
41 |
0.000265 |
0.006165 |
200 |
RECEPTOR CLUSTERING |
3 |
41 |
0.000265 |
0.006165 |
201 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
10 |
872 |
0.0002819 |
0.006527 |
202 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
5 |
191 |
0.0002907 |
0.006697 |
203 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
5 |
192 |
0.0002978 |
0.006793 |
204 |
CEREBRAL CORTEX DEVELOPMENT |
4 |
105 |
0.0002974 |
0.006793 |
205 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
4 |
106 |
0.0003084 |
0.006999 |
206 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
6 |
303 |
0.0003174 |
0.007168 |
207 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
4 |
107 |
0.0003196 |
0.007185 |
208 |
REGULATION OF CELL CYCLE ARREST |
4 |
108 |
0.0003312 |
0.007408 |
209 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
6 |
306 |
0.0003345 |
0.007412 |
210 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
8 |
573 |
0.0003345 |
0.007412 |
211 |
NEGATIVE REGULATION OF CELL CYCLE |
7 |
433 |
0.0003382 |
0.007458 |
212 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
4 |
109 |
0.000343 |
0.007528 |
213 |
POSITIVE REGULATION OF RECEPTOR ACTIVITY |
3 |
45 |
0.0003497 |
0.007634 |
214 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
5 |
199 |
0.0003511 |
0.007634 |
215 |
IN UTERO EMBRYONIC DEVELOPMENT |
6 |
311 |
0.0003646 |
0.007855 |
216 |
RESPONSE TO OXYGEN LEVELS |
6 |
311 |
0.0003646 |
0.007855 |
217 |
REGULATION OF ION HOMEOSTASIS |
5 |
201 |
0.0003676 |
0.007882 |
218 |
ZYMOGEN ACTIVATION |
4 |
112 |
0.0003803 |
0.008118 |
219 |
OVULATION CYCLE |
4 |
113 |
0.0003934 |
0.008358 |
220 |
REGULATION OF ION TRANSPORT |
8 |
592 |
0.0004157 |
0.008793 |
221 |
FEMALE SEX DIFFERENTIATION |
4 |
116 |
0.0004345 |
0.009148 |
222 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
7 |
452 |
0.0004376 |
0.009171 |
223 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
6 |
323 |
0.0004457 |
0.009299 |
224 |
REGULATION OF NEURONAL SYNAPTIC PLASTICITY |
3 |
49 |
0.0004501 |
0.009349 |
225 |
SKELETAL SYSTEM DEVELOPMENT |
7 |
455 |
0.0004552 |
0.009414 |
226 |
TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY |
4 |
118 |
0.0004636 |
0.009544 |
227 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
5 |
213 |
0.0004791 |
0.00982 |